Channel Medsystems(R) Receives FDA Approval of its Latest Cerene(R) Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding in the Office Setting

Next-generation technology enhances ease-of-use for physicians and streamlines manufacturability The Company is targeting limited market introduction in Q42020 and commercial launch of the Cerene® Device in the first half of 2021 EMERYVILLE, Cali... Devices, FDA Channel Medsystems, Cerene, Cryotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news